Docetaxel Injection Usp (2019-10-04)

Docetaxel Injection USP Recall Docetaxel Injection USP has been recalled across Canada due to product safety concerns. Docetaxel is a chemotherapy drug used to treat certain cancers. The recall affects all patients and healthcare providers who have received or are using this medication.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2019-10-04
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/c7aac553-c15f-462c-bf82-6a3576003949